Efficacy and tolerability of lumiracoxib in the treatmentof osteoarthritis of the knee: A 13-week, randomized, double-blind comparison with celecoxib and placebo
- 31 January 2005
- journal article
- clinical trial
- Published by Elsevier BV in Clinical Therapeutics
- Vol. 27 (1), 64-77
- https://doi.org/10.1016/j.clinthera.2005.01.002
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Efficacy and Safety of Rofecoxib 12.5 mg Versus Nabumetone 1,000 mg in Patients with Osteoarthritis of the Knee: A Randomized Controlled TrialJournal of the American Geriatrics Society, 2004
- Health-related quality of life among older adults with arthritisHealth and Quality of Life Outcomes, 2004
- EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)Annals Of The Rheumatic Diseases, 2003
- Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trialsBMJ, 2002
- Update of ACR Guidelines for Osteoarthritis: Role of the CoxibsJournal of Pain and Symptom Management, 2002
- The hidden costs of arthritis treatment and the cost of new therapy--the burden of non-steroidal anti-inflammatory drug gastropathyRheumatology, 2002
- Epidemiologic assessment of the safety of conventional nonsteroidal anti-inflammatory drugsAmerican Journal Of Medicine, 2001
- Celecoxib versus diclofenac in the management of osteoarthritis of the knee: A placebo-controlled, randomised, double-blind comparisonScandinavian Journal of Rheumatology, 2001
- Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 updateArthritis & Rheumatism, 2000
- Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory DrugsThe New England Journal of Medicine, 1999